• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 34 of 100
Photo of CEPI Deputy Director Frederik Kristensen
HealthWhich COVID-19 vaccine works best? A new lab network promises an answer
By Jeremy KahnOctober 6, 2020
Trump is being treated with a COVID drug that wasn’t one of the questionable therapies he’s previously touted
HealthTrump is being treated with a COVID drug that wasn’t one of the questionable therapies he’s previously touted
By Sy MukherjeeOctober 2, 2020
Key Speakers At The 2017 Milken Conference
NewslettersBristol Myers Squibb and Celgene got a beating in Congress on drug prices—but only Congress can fix the problem
By Sy MukherjeeOctober 1, 2020
How 3 of biopharma’s most powerful women are building public trust during COVID
ConferencesHow 3 of biopharma’s most powerful women are building public trust during COVID
By Sy MukherjeeSeptember 29, 2020
Photo of D-Wave CEO Alan Baratz.
TechD-Wave unveils its most powerful quantum computer to date
By Jeremy KahnSeptember 29, 2020
Alzheimer's COVID drug development FDA
HealthThe world is obsessed with new COVID drugs. But other important treatments are in the works, too
By Sy MukherjeeSeptember 28, 2020
To ethically tackle COVID-19, Big Pharma needs an overhaul
CommentaryTo ethically tackle COVID-19, Big Pharma needs an overhaul
By Nicole HassounSeptember 25, 2020
Portrait of Pascal Soriot, AstraZeneca CEO
HealthUnder fire, AstraZeneca CEO defends transparency of COVID-19 vaccine trials
By Jeremy KahnSeptember 24, 2020
Paul Stoffels-J&J
HealthWill the pandemic give us a Sputnik moment?
By Erika FrySeptember 23, 2020
Illustration of coronavirus particles. Coronaviruses are a group of viruses named for their appearance under electron microscopy, where their round-tipped surface spikes make them resemble a crown.
HealthResearchers find a ‘druggable pocket’ in coronavirus that could lead to new antivirals
By David MeyerSeptember 22, 2020
CNV.10.20.Bill Gates Horizontal Featured
MagazineWhen Bill Gates thinks we’ll have a COVID-19 vaccine—and why that won’t be the end of the pandemic
By Clifton LeafSeptember 21, 2020
‘We’re racing against the clock’: The CEO of the Serum Institute of India on his company’s COVID-19 vaccine campaign
Health‘We’re racing against the clock’: The CEO of the Serum Institute of India on his company’s COVID-19 vaccine campaign
By Erika FrySeptember 21, 2020
General Views of Eli Lilly & Co.
NewslettersEli Lilly is teaching an old drug technology new tricks against COVID—and has promising early results
By Sy MukherjeeSeptember 17, 2020
Coronavirus Vaccine Research at Valneva SA Labs
NewslettersThe rollercoaster of COVID-19 vaccines
By Sy MukherjeeSeptember 10, 2020
Pfizer coronavirus vaccine Fortune
HealthPfizer’s CEO is still hopeful for COVID vaccine progress by October—and says a sense of purpose is fueling him
By Sy MukherjeeSeptember 9, 2020
1...
  • 32
  • 33
  • 34
  • 35
  • 36
...100
Most Popular
Real Estate
Gen Z fled San Francisco for Texas and Florida. Now they’re turning ‘welcomer cities’ into the next big tech townsplaceholder alt text
By Sydney LakeJune 13, 2026
Startups & Venture
Melinda French Gates' advice to new IPO millionaires: 'Give half your money away'placeholder alt text
By Emma HinchliffeJune 13, 2026
AI
Anthropic disables Fable and Mythos AI models after U.S. government bars it from giving foreigners accessplaceholder alt text
By Jeremy KahnJune 13, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.